Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY).

Taiji SakamotoMasahiko ShimuraShigehiko KitanoMasahito OhjiYuichiro OguraHidetoshi YamashitaMakoto SuzakiKimie MoriYohei OhashiPoh Sin YapTakeumi KanekoTatsuro Ishibashinull null

Published in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)

MERCURY study data confirm the effectiveness of real-world treatment initiated with ranibizumab in Japanese patients with DME. In addition, treatment was able to positively influence anxiety via VA improvement.

Keyphrases

diabetic retinopathy
randomized controlled trial
type diabetes
systematic review
metabolic syndrome
adipose tissue
insulin resistance
sleep quality
age related macular degeneration